Article
Thiamine-responsive megaloblastic anemia syndrome with novel compound heterozygous SLC19A2 mutations and thrombotic events: a case report.
Journal of medical case reports - 16 Mar 2026
Jiménez Francisco Xavier, Rojas Carlos, Fernandez Heidi A, Ruiz-Urbáez Rossana, Reyes-Silva Carlos, Guamán Jhonatan, Carrión Mauricio, Naranjo-Saltos Fernando
Abstract excerpt
BACKGROUND: Thiamine-responsive megaloblastic anemia syndrome represents a rare autosomal recessive condition originating from mutations in the SLC19A2 gene. It is characterized by a classical triad of megaloblastic anemia, insulin-dependent diabetes mellitus, and sensorineural hearing loss. We present the case of a woman diagnosed with thiamine-responsive megaloblastic anemia, with no history of consanguinity,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
